ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 225 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $202,133 | -1.6% | 7,396 | -0.1% | 0.01% | -25.0% |
| Q2 2023 | $205,368 | -16.5% | 7,406 | +0.1% | 0.01% | -20.0% |
| Q1 2023 | $245,991 | +3.4% | 7,396 | +6.3% | 0.01% | -9.1% |
| Q3 2022 | $238,000 | +1.3% | 6,956 | +2.8% | 0.01% | 0.0% |
| Q2 2022 | $235,000 | -20.0% | 6,766 | +1.3% | 0.01% | -15.4% |
| Q1 2022 | $293,654 | -31.5% | 6,677 | -2.3% | 0.01% | -27.8% |
| Q4 2021 | $429,000 | -18.8% | 6,833 | +36.5% | 0.02% | -28.0% |
| Q3 2021 | $528,000 | -34.5% | 5,007 | +10.8% | 0.02% | -37.5% |
| Q2 2021 | $806,000 | +41.2% | 4,519 | +3.6% | 0.04% | +25.0% |
| Q1 2021 | $571,000 | +28.0% | 4,362 | +32.3% | 0.03% | 0.0% |
| Q4 2020 | $446,000 | +90.6% | 3,296 | +17.3% | 0.03% | +52.4% |
| Q3 2020 | $234,000 | +1.7% | 2,810 | +0.2% | 0.02% | -8.7% |
| Q2 2020 | $230,000 | – | 2,804 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
| Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
| Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
| HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
| Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
| Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
| Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
| Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |